Replies to post #137678 on Biotech Values

[ghmm]

I don't follow the stock but are you (or anyone else) surprised there weren't more no's just based on the CV issues? I heard parts of the panel and early on there seemed to be one or two panelists raising concern there.

[DewDiligence]

VVUS—This might be a good time to review the table in #msg-59407483 :- )

Note that Contrave is one of the items on the list.